A novel gene carrier based on amino-modified silica nanoparticles

被引:19
作者
He, XX [1 ]
Wang, KM [1 ]
Tan, WH [1 ]
Liu, B [1 ]
Lin, X [1 ]
Huang, SS [1 ]
Li, D [1 ]
He, CM [1 ]
Li, J [1 ]
机构
[1] Hunan Univ, Inst Biol Technol, State Key Lab Chemobiosensing & Chemometr, Coll Chem & Chem Engn, Changsha 410082, Peoples R China
来源
CHINESE SCIENCE BULLETIN | 2003年 / 48卷 / 03期
基金
中国国家自然科学基金;
关键词
gene carrier; nanoparticle; amino-modified silica;
D O I
10.1360/03tb9046
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Uniform-sized amino-modified silica nanoparticles have been prepared by the controlled synchronous hydrolysis of tetraethoxysilane and N-(beta-amimoethyl)-gamma-aminopropyltriethoxysilane in water nanodroplet of the water-in-oil microemulsion. These nanoparticles; display positive charge potential at definited pH. This is due to the presence of amino groups on the surface of the nanoparticles. Nanoparticles-plasmid DNA complexes can easily form through electrostatical binding between the positive charges of the amino-modified silica nanoparticles and the negative charges of the plasmid DNA. The complexes can be also dissociated under alkaline pH or high ionic strength conditions. And enzymatic digestion of the plasmid DNA is almost inhibited by these nanoparticles complexes. A novel non-viral gene carrier based on the amino-modified silica nanoparticles is proposed under the combination of nanotechnology, biotechnology and gene engineering technology. The plasmid DNA can successfully cross various systemic barriers to COS-7 cells as well as mediate high expression of Green Fluorescence Protein (GFP) gene in cells by use of this novel gene carrier.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 20 条
  • [1] Aderson W., 1998, NATURE, V392, P25
  • [2] LIPOSOMES AS VACCINE CARRIERS - INCORPORATION OF SOLUBLE AND PARTICULATE ANTIGENS IN GIANT VESICLES
    ANTIMISIARIS, SG
    JAYASEKERA, P
    GREGORIADIS, G
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 166 (02) : 271 - 280
  • [3] Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro
    Bender, AR
    vonBriesen, H
    Kreuter, J
    Duncan, IB
    RubsamenWaigmann, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) : 1467 - 1471
  • [4] BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P9297
  • [5] DAVIS PJ, 1997, CONT ENDOCRINOL, V2, P17
  • [6] Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability
    Erbacher, P
    Zou, SM
    Bettinger, T
    Steffan, AM
    Remy, JS
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (09) : 1332 - 1339
  • [7] Calcium phosphate nanoparticle adjuvant
    He, Q
    Mitchell, AR
    Johnson, SL
    Wagner-Bartak, C
    Morcol, T
    Bell, SJD
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (06) : 899 - 903
  • [8] HE SS, 2001, CHINESE SCI BULL, V46, P1962
  • [9] Photostable luminescent nanoparticles as biological label for cell recognition of system lupus erythematosus patients
    He, XX
    Wang, KM
    Tan, WH
    Li, J
    Yang, XH
    Huang, SS
    Li, D
    Xiao, D
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2002, 2 (3-4) : 317 - 320
  • [10] Biomedical application of functional polymers (vol 39, pg 99, 1999)
    Jagur-Grodzinski, J
    [J]. REACTIVE & FUNCTIONAL POLYMERS, 1999, 40 (02) : 185 - 185